Intranasal Oxytocin as Add-On Treatment for Inpatients with Severe Mental Illness: A Randomized Clinical Trial

Keyphrases

• Severe Mental Illness 100%
• Add-on Treatment 100%
• Treatment Outcome 100%
• Randomized Clinical Trial 100%
• Intranasal Oxytocin 100%
• Placebo Groups 66%
• Working Alliance 66%
• Oxytocin 66%
• Israel 33%
• Placebo 33%
• Therapist 33%
• Depressive Symptoms 33%
• Anxiety Symptoms 33%
• Randomized Controlled Trial 33%
• Twice Daily 33%
• Large Gain 33%
• Psychiatric Hospital 33%
• Psychiatric Inpatients 33%
• Therapy Treatment 33%
• Multilevel Modeling 33%
• Usual Care 33%
• Therapy Session 33%
• Female Participants 33%
• Symptomatic Improvement 33%
• Treatment Process 33%
• Therapy Process 33%
• Placebo-controlled Randomized Trial 33%
• General Distress 33%
• Oxytocin Administration 33%
• Experimental Methodology 33%
• Intervening Factors 33%
• Session Outcome 33%
• Linear Change 33%
• Workplace Attachment 33%
• Inpatient Setting 33%

Neuroscience

• Oxytocin 100%
• Severe Mental Illness 100%
• Placebo 80%
• Randomized Controlled Trial 40%

Psychology

• Mental Illness 100%
• Oxytocin 100%
• Multi-Level Modeling 20%